πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

First People's Hospital Pipeline

All ClinicalTrials.gov programs at First People's Hospital β€” phase, modality, and trial IDs.

Programs
1,136

Quick answer

First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Metformin

    The First People's Hospital of Lianyungang

    Type2 Diabetes

    phase 1 small molecule active

    1 trial

  2. NGGT002 Injection

    The First People's Hospital of Lianyungang

    Phenylketonurias

    phase 1 gene therapy active

    1 trial

  3. PRG2302

    The First People's Hospital of Lianyungang

    Acute Lymphoblastic Leukemia

    phase 1 small molecule active

    1 trial

  4. Pemetrexed

    The First People's Hospital of Lianyungang

    Leptomeningeal Metastases

    phase 1 small molecule completed

    1 trial

  5. Placebo

    The First People's Hospital of Lianyungang

    Asthma

    phase 1 small molecule active

    1 trial

  6. Prizloncabtagene Autoleucel

    The First People's Hospital of Lianyungang

    Non-Hodgkin's B-cell Lymphoma

    phase 1 mab active

    1 trial

  7. Probiotic

    The First People's Hospital of Lianyungang

    Microbiota

    phase 1 small molecule active

    1 trial

  8. Proxalutamide

    The First People's Hospital of Lianyungang

    Metastatic Breast Cancer

    phase 1 small molecule completed

    1 trial

  9. REGEND001

    The First People's Hospital of Lianyungang

    Idiopathic Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  10. Recombinant NV-A01 adenovirus injection

    The First People's Hospital of Lianyungang

    Advanced Glioblastoma Patients

    phase 1 small molecule active

    1 trial

  11. Risperidone

    The First People's Hospital of Lianyungang

    Schizophrenia

    phase 1 small molecule active

    1 trial

  12. Ritonavir Tablet 100mg

    The First People's Hospital of Lianyungang

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  13. Ritonavir for cycle1 and NORVIR for cycle 2

    The First People's Hospital of Lianyungang

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  14. Rituximab

    The First People's Hospital of Lianyungang

    Diffuse Large B-cell Lymphoma Recurrent

    phase 1 small molecule active

    1 trial

  15. SCT510

    The First People's Hospital of Lianyungang

    Healthy

    phase 1 small molecule completed

    1 trial

  16. SIG001

    The First People's Hospital of Lianyungang

    Neoplams

    phase 1 mab active

    1 trial

  17. SZ011 CAR-NK

    The First People's Hospital of Lianyungang

    Advanced Triple Negative Breast Cancer

    phase 1 small molecule active

    1 trial

  18. Salvianolic Acid A

    The First People's Hospital of Lianyungang

    Neuropathy of Diabetes

    phase 1 small molecule active

    1 trial

  19. Serine（OralοΌ‰

    The First People's Hospital of Lianyungang

    Advanced Colorectal Cancer

    phase 1 small molecule active

    1 trial

  20. Shenkang decoction

    The First People's Hospital of Lianyungang

    Chronic Renal Failure

    phase 1 small molecule completed

    1 trial

  21. Sonodynamic therapy (SDT)

    The First People's Hospital of Lianyungang

    Carotid Atherosclerosis

    phase 1 other completed

    1 trial

  22. T cell injection targeting CD7 chimeric antigen receptor

    The First People's Hospital of Lianyungang

    T Lymphoblastic Leukemia/Lymphoma

    phase 1 mab active

    1 trial

  23. T cell injection targeting CD7 chimeric antigen receptor

    The First People's Hospital of Lianyungang

    CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies

    phase 1 mab active

    1 trial

  24. TALEN

    The First People's Hospital of Lianyungang

    Human Papillomavirus-Related Malignant Neoplasm

    phase 1 mab active

    1 trial

  25. TCR-T cells

    The First People's Hospital of Lianyungang

    Recurrent Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  26. TNP-2092 capsules

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    phase 1 small molecule completed

    1 trial

  27. ThisCART19A

    The First People's Hospital of Lianyungang

    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    phase 1 small molecule active

    1 trial

  28. ThisCART19A with Dose Level 1

    The First People's Hospital of Lianyungang

    CAR

    phase 1 small molecule active

    1 trial

  29. ThisCART22 cells injection

    The First People's Hospital of Lianyungang

    B Cell Malignancy

    phase 1 mab active

    1 trial

  30. Tranilast

    The First People's Hospital of Lianyungang

    Mucinoses

    phase 1 small molecule active

    1 trial

  31. Triprorelin for injection

    The First People's Hospital of Lianyungang

    Prostate Cancer (CRPC)

    phase 1 small molecule active

    1 trial

  32. U96

    The First People's Hospital of Lianyungang

    Relapsed or Refractory B Cell Leukemia and Lymphoma

    phase 1 small molecule active

    1 trial

  33. UB-VV410

    The First People's Hospital of Lianyungang

    Systemic Lupus Erythematosus

    phase 1 small molecule active

    1 trial

  34. UTAA09 injection

    The First People's Hospital of Lianyungang

    Recurrent or Refractory B-cell Non Hodgkin's Lymphoma

    phase 1 mab active

    1 trial

  35. Visual Sputum Suctioning System

    The First People's Hospital of Lianyungang

    Ineffective Airway Clearance

    phase 1 other active

    1 trial

  36. Voriconazole 200mg

    The First People's Hospital of Lianyungang

    Cryptococcal Meningitis

    phase 1 small molecule active

    1 trial

  37. [14C]HSK7653

    The First People's Hospital of Lianyungang

    Type II Diabetes

    phase 1 small molecule completed

    1 trial

  38. [14C]TGRX-326

    The First People's Hospital of Lianyungang

    Non Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  39. [177Lu]Lu-XT117

    The First People's Hospital of Lianyungang

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  40. [18F]APN-1607

    The First People's Hospital of Lianyungang

    Alzheimer Disease

    phase 1 small molecule active

    1 trial

  41. [68Ga]Ga-Sa-DABI-4

    The First People's Hospital of Lianyungang

    Stimulator of Interferon Gene

    phase 1 small molecule active

    1 trial

  42. aerosol inhaled amikacin

    The First People's Hospital of Lianyungang

    Chronic Obstructive Pulmonary Disease (COPD)

    phase 1 small molecule completed

    1 trial

  43. anti CD19 CAR NK cells

    The First People's Hospital of Lianyungang

    Antisynthetase Syndrome

    phase 1 mab active

    1 trial

  44. anti-CD19 CAR-T

    The First People's Hospital of Lianyungang

    B-cell Adult Acute Lymphoblastic Leukemia

    phase 1 mab active

    1 trial

  45. anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells

    The First People's Hospital of Lianyungang

    Relapsed/refractory Lymphoma

    phase 1 mab active

    1 trial

  46. blinatumomab and auto-HSCT "sandwich " strategy

    The First People's Hospital of Lianyungang

    B-cell Acute Lymphoblastic Leukemia

    phase 1 other active

    1 trial

  47. bronchial basal cells

    The First People's Hospital of Lianyungang

    Chronic Respiratory Disease

    phase 1 mab active

    1 trial

  48. cisplatin oxaliplatin tegafur

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does First People's Hospital have?

1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.